期刊文献+

用牛颈静脉制备抗栓 抗钙化性右心流出道修复材料的实验研究 被引量:1

Experimental study on bovine jugular vein used to prepare prostheses with antithrombotic and anticalcific prop-erties for right ventricular outflow tract
下载PDF
导出
摘要 目的论证用牛颈静脉制备抗栓、抗钙化右心流出道修复材料的可行性。方法用EX-313交联牛颈静脉带瓣胶原管道并用肝素处理其内壁,裁成带单瓣的补片,用其扩大7条犬的肺动脉,同时建立用戊二醛制成的补片扩大肺动脉对照模型。在6个月内观察补片的抗栓、抗钙化、内皮化及组织重构的情况。结果在抗栓、抗钙化、内皮化及组织重构方面EX-313及肝素处理的牛颈静脉明显优于戊二醛处理者。结论经亲水性交联剂EX-313及肝素处理内壁的牛颈静脉有可能成为制作重建右心流出道的基本材料,在进一步研究的基础上它也可能成为组织工程带瓣管道的支架材料。 Objective To demonstrate the feasibility that bovine jugular vein be used as the potential repairing material with high anticalcification and antithrombogenesis for reconstructing the right ventricular outflow tract.Methods Establishing two kinds of the canine model of patching pulmonary artery with the patch incorporated single valve alterna-tively treated with EX-313/heparin and glutaraldehyde.In a period of six months the specimens were taken to compare the thrombogenesis,calcium deposition and endothelialization between the two groups.Results The anticalcification,antithrom-bogenesis and accelerating tissue reconstruction in EX-313/heparin treated group was superior to that in the glutaralde-hyde treated group.Conclusion The EX-313/heparin-treated bovine jugular vein may be used as a useful material for re-constructing right ventricular outflow tract,and on the basis of further investigation,the collagenous tube with valves de-rived from bovine jugular vein can be chosen for the scaffold of tissue engineered valved conduit.
出处 《中国药物与临床》 CAS 2004年第1期25-27,T001,共4页 Chinese Remedies & Clinics
基金 国家自然科学基金资助项目(39870207)
关键词 牛颈静脉 肝素 右心流出道修复材料 抗栓作用 抗钙化作用 带瓣管道 治疗 Cattle Jugular veins Anticalcification Heparin Valved conduit
  • 相关文献

参考文献9

  • 1[1]Byung-Soon K,Carlos EB,Anthony A.Biomaterials for tissueengineering. World J Urol,2000,18:2-9.
  • 2[2]Noishiki YH,Yamane YH,Okoshi TF,et al. Choice,isolation and preparation of cells for bioartificial vascular grafts. Artifi Organs,1998,22(1):50-62.
  • 3[3]Ichikawa YK, Noishiki YH, Soma TM, et al. A new antithrombogenic RV-PA valved conduit. ASAIO J, 1994,40:714-718.
  • 4[4]Ichikawa YK, Noishiki YH, Kosuge TY, et al. Use of a bovine jugular vein graft with natural valved for right ventricular outflow tract reconstruction: a one year animal study. J Thorac Cardiovasc Surg,1997,114:224-233.
  • 5[7]Hsing WS, Roger Tu, Shen SH, et al. A new developed porcine heart valve bioprosthesis fixed with an epoxy compound:an experimental evaluation. ASAIO J,1994,40:192-198.
  • 6[8]Tang ZG,Yue YL. Crosslinkage of collagen by polyglycidyl ethers. ASAIO J O, 1995,41:72-78.
  • 7[9]Shinika TH, Dominique ST, Peter X Ma,et al.Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg, 1998,115:536-546.
  • 8[10]Stock UA,Nagashima M, Khalil PN,et al. Tissue-engineered valved conduits in the pulmonary circulation. J Thorac Cardiovasc Surg,2000,119:732-740.
  • 9[11]Stock UA,Sakamoto T,Hatsuka S,et al. Patch augmentation of the pulmonary artery with bioabsorbable polymers and autologous seeding. J Thorac C ardiovasc Surg, 2000,120:1158-1168.

同被引文献15

  • 1李悟,刘维永,刘洋,谭红梅.去细胞牛颈静脉带瓣管道支架生物学与生物力学特性的初步研究[J].中国胸心血管外科临床杂志,2005,12(6):406-409. 被引量:2
  • 2Ichikawa Y. A new RV-pa conduit with a natural valve made of bovine jugular vein. Asaio J, 1992, 38(3) : M266-M270.
  • 3Delmo-walter EM, Alexi-meskishvili V, Abdul-khaliq H, et al. Aneurysmal dilatation of the contegra bovine jugular vein conduit after reconstruction of the right ventricular outflow tract. Ann Thorac Surg , 2007, 88(2): 682-684.
  • 4Breymann T, Blanz U, Wojtalik MA, et al. European contegra multieentre study:7-year results after 165 valved bovine jugular vein graft implantations. Thorac Cardiovase Surg, 2009, 57(5) : 257-269.
  • 5Korossis SA, Booth C, Wilcox HE, et al. Tissue engineering of cardiac valve prostheses Ⅱ: biomechanical characterization of decellularized porcine aortic heart valves. Heart Valve Dis, 2002, 11(4): 463-471.
  • 6Shebani SO, Mcguirk S, Baghai M, et al. Right ventricular outflow tract reconstruction using contegra valved conduit: natural history and conduit performance under pressure. Eur J Cardiothorac Surg , 2006, 29(3): 397-405.
  • 7Bezuidenhout D, Oosthuysen A, Human P, etal. The effects of cross-link density and chemistry on the calcification potential of diamine-extended glutaraldehyde-fixed bioprosthetic heart-valve materials. Bioteehnol Appl Bioehem, 2009, 54(3) :133-140.
  • 8Everaerts F, Gillissen M, Torrianni M, et al. Reduction of calcification of carbodiimide-processed heart valve tissue by prior blocking of amine groups with monoaldehydes. Heart Valve Dis, 2006, 15(2):269-277.
  • 9Manji RA, Zhu LF, Nijjar NK, et al. Glutaraldehyde-fixedbioprosthetic heart valve conduits calcify and fail from xenograft rejeetion. Circulation, 2006, 114(4): 318-327,.
  • 10Neethling WM, Glancy R, Hodge AJ. Mitigation of calcification and eytotoxicity of a glutaraldehyde-preserved bovine pericardiaI matrix:improved bioeompatibility after extended implantation in the subcutaneous rat model. J Heart Valve Dis, 2010, 19(6): 778-785.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部